正川转债

Search documents
重庆正川医药包装材料股份有限公司可转债转股结果暨股份变动公告
Shang Hai Zheng Quan Bao· 2025-10-09 18:46
证券代码:603976 证券简称:正川股份 公告编号:2025-064 债券代码:113624 债券简称:正川转债 重庆正川医药包装材料股份有限公司 可转债转股结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 累计转股情况:截至2025年9月30日,累计共有人民币170,000.00元"正川转债"已转换成公司股票,累 计因转股形成的股份数量为3,652股,占"正川转债"转股前公司已发行股份总额的0.0024%。 ● 未转股可转债情况:截至2025年9月30日,尚未转股的"正川转债"金额为人民币404,830,000.00元, 占"正川转债"发行总额的99.9580%。 ● 本季度转股情况:2025年7月1日至2025年9月30日期间,共有人民币71,000元"正川转债"已转换为公司 股票,因转股形成的股份数量为1,550股。 一、可转债发行上市概况 (二)可转债上市情况 (一)可转债发行情况 经中国证券监督管理委员会证监许可[2021]198号《关于核准重庆正川医药包装材料股份有限公司公开 ...
9月22日投资提示:正川转债提议下修
集思录· 2025-09-21 14:26
Group 1 - The core viewpoint of the article discusses recent developments in convertible bonds, including proposals for adjustments and shareholder actions [1][2][4][6] - Zhengchuan Convertible Bond has proposed a downward adjustment [1][2] - Outoong Convertible Bond will not be forcibly redeemed [1][2] - Haibo Heavy Industry plans to reduce its holdings by no more than 1% of repurchased shares [1] - Guanzhong Ecology is planning a change in control and has suspended trading [1] - Ruifeng High Materials' shareholders intend to reduce their holdings by no more than 0.96% [1] Group 2 - A table lists various convertible bonds with their current prices, redemption prices, last trading dates, last conversion dates, conversion values, remaining scales, and the proportion of convertible bonds to the underlying stocks [4][6] - For example, the current price of Jiaojian Convertible Bond is 162.161, with a redemption price of 100.044, and a conversion value of 162.90 [4] - The remaining scale of Jinxian Convertible Bond is 0.145 billion, with a market value ratio of 0.39% [4] - The current price of Dongjie Convertible Bond is 261.820, with a conversion value of 265.84 and a remaining scale of 0.731 billion [4]
重庆正川医药包装材料股份有限公司第四届董事会第二十四次会议决议公告
Shang Hai Zheng Quan Bao· 2025-09-19 18:56
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:603976 证券简称:正川股份 公告编号:2025-056 本次会议由董事长邓勇先生召集和主持。会议的召集、召开和表决程序均符合《公司法》等法律、行政 法规以及《公司章程》《公司董事会议事规则》的有关规定,会议的召集、召开合法有效。 二、董事会会议审议情况 本次会议审议通过了《关于向下修正"正川转债"转股价格的议案》 债券代码:113624 债券简称:正川转债 重庆正川医药包装材料股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 重庆正川医药包装材料股份有限公司(以下简称"公司")于2025年9月15日以电子邮件或电话等形式向 各位董事发出了召开第四届董事会第二十四次会议的通知。会议于2025年9月19日以现场结合通讯方式 在正川永成研发楼三楼会议室召开,应参加董事9名,实际参加董事9名。 第四届董事会第二十四次会议 决议公告 根据公司《公开发行可转换公司债券募集说明书》(以下简称"募集说明书")的有关规定,自2025年8 月30 ...
正川股份:关于董事会提议向下修正“正川转债”转股价格的公告
Zheng Quan Ri Bao· 2025-09-19 10:44
Group 1 - The company announced a proposal to adjust the conversion price of "Zhengchuan Convertible Bonds" during the 24th meeting of its fourth board of directors [2]
正川股份: 关于“正川转债”可选择回售结果的公告
Zheng Quan Zhi Xing· 2025-06-30 16:24
Group 1 - The company announced the results of the bond repurchase for "Zhengchuan Convertible Bond" with a repurchase price of 100.35 RMB per bond, including current interest [1][2] - The repurchase period was from June 20, 2025, to June 26, 2025, during which the effective repurchase applications amounted to 0 bonds and 0 RMB [1][2] - The company will not need to handle any subsequent payment processes to investors as there were no valid repurchase applications [2] Group 2 - The repurchase of "Zhengchuan Convertible Bond" will not have a significant impact on the company's cash flow, asset status, or share capital [2] - Unredeemed "Zhengchuan Convertible Bonds" will continue to be traded on the Shanghai Stock Exchange [2]
正川股份: 关于“正川转债”可选择回售的第一次提示性公告
Zheng Quan Zhi Xing· 2025-06-15 10:17
Key Points - The company, Chongqing Zhengchuan Pharmaceutical Packaging Materials Co., Ltd., will initiate the conditional redemption of its convertible bonds, Zhengchuan Convertible Bonds, starting from April 28, 2025, due to the stock price being below 70% of the conversion price for 30 consecutive trading days [1][2] - The redemption price for the bonds is set at 100.35 RMB per bond, which includes the accrued interest [3][4] - The redemption period is from June 20, 2025, to June 26, 2025, during which the bonds will stop converting into shares [3][5] - Holders of the Zhengchuan Convertible Bonds have the option to redeem either part or all of their unconverted bonds, and this redemption is not mandatory [4][5] - The company will announce the results of the redemption and its impact on the company after the redemption period [4][5]
重庆正川医药包装材料股份有限公司关于“正川转债”可选择回售的公告
Shang Hai Zheng Quan Bao· 2025-06-12 18:21
Core Viewpoint - The company announces the conditional redemption of its convertible bonds, "Zhengchuan Convertible Bonds," allowing bondholders to sell their bonds back to the company at a specified price during a designated period [2][3][7]. Redemption Terms - The redemption price is set at 100.35 RMB per bond, including the current interest [2][11]. - The redemption period is from June 20, 2025, to June 26, 2025, during which the bonds will stop converting into shares [4][10]. - If bondholders do not exercise their redemption rights during this period, they will lose the opportunity to redeem for the current interest year [2][3]. Conditions for Redemption - The redemption clause is activated if the company's stock price remains below 70% of the bond's conversion price for 30 consecutive trading days [3][5]. - The bondholders have the option to redeem part or all of their unconverted bonds, and this redemption is not mandatory [7][8]. Interest Calculation - The interest for the current period is calculated based on a 2.40% annual rate, resulting in approximately 0.35 RMB per bond for the 53 days from April 28, 2025, to June 20, 2025 [6][12]. Trading During Redemption Period - The "Zhengchuan Convertible Bonds" will continue to trade during the redemption period but will not allow conversion into shares [14]. - If the total face value of the bonds in circulation falls below 30 million RMB due to redemptions, the bonds will still continue to trade until the end of the redemption period [15].
正川股份: 关于可转换公司债券2025年跟踪评级结果的公告
Zheng Quan Zhi Xing· 2025-06-10 10:51
Group 1 - The core viewpoint of the announcement is that the credit rating for Chongqing Zhengchuan Pharmaceutical Packaging Materials Co., Ltd. remains unchanged at "A+" for both the company and its convertible bonds, with a stable outlook [1][2]. - The previous credit rating was also "A+" for both the company and the convertible bonds, with a stable outlook, indicating consistency in the company's financial health [2]. - The credit rating was conducted by United Credit Rating Co., Ltd., based on a comprehensive analysis of the company's operational and industry conditions [2]. Group 2 - The announcement confirms that the tracking credit rating report is available on the Shanghai Stock Exchange website for further details [2].
重庆正川医药包装材料股份有限公司关于实施2024年度权益分派时“正川转债”停止转股的提示性公告
Shang Hai Zheng Quan Bao· 2025-05-08 21:03
Group 1 - The company will stop the conversion of its convertible bonds "Zhengchuan Convertible Bonds" from May 14, 2025, until the equity registration date due to the implementation of the 2024 profit distribution plan [1][3] - The profit distribution plan involves a cash dividend of 2.46 yuan per 10 shares (including tax) to all shareholders, with no capital reserve conversion to share capital or bonus shares [2][3] - The profit distribution plan was approved at the annual general meeting held on April 30, 2025, and details will be disclosed on the Shanghai Stock Exchange and other designated media [2][3] Group 2 - The company will announce the implementation of the profit distribution and the adjustment of the conversion price for the convertible bonds on May 15, 2025 [3] - Holders of "Zhengchuan Convertible Bonds" must convert their bonds before May 13, 2025, to enjoy the benefits of the profit distribution [3]
重庆正川医药包装材料股份有限公司 关于“正川转债”预计满足转股价格修正条件的 提示性公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-04-23 01:19
Group 1 - The company issued 4.05 million convertible bonds with a total fundraising amount of RMB 405 million, with a maturity of 6 years and a tiered interest rate structure [2][3] - The initial conversion price was set at RMB 46.69 per share, which has been adjusted multiple times due to annual profit distributions [3][4] - The latest conversion price is RMB 46.02 per share, with further adjustments planned for future profit distributions [4] Group 2 - The company has a downward adjustment clause for the conversion price, which can be triggered if the stock price falls below 90% of the current conversion price for at least 15 out of 30 consecutive trading days [5][6] - If the adjustment condition is met, the board will propose a new conversion price to be voted on by shareholders [7] - The expected trigger period for the conversion price adjustment is from April 9, 2025, to April 22, 2025, with a specific price threshold of RMB 41.418 per share [7]